发明名称 |
METHODS OF ASSESSING AND IDENTIFYING OR EVOLVING CONDITIONALLY ACTIVE THERAPEUTIC PROTEINS |
摘要 |
PROBLEM TO BE SOLVED: To provide methods of evolving or selecting therapeutic proteins that exhibit reduced adverse side-effects, and resulting proteins.SOLUTION: Provided herein is an in vitro assay for identifying conditionally active therapeutic proteins that exhibit better activity within one in vivo environment compared to another in vivo environment. A method includes steps of; a) testing activity of a protein under conditions in which normal or increased activity is desired; b) testing activity of the protein under conditions in which reduced activity compared to normal is desired; and c) comparing the activity in a) with b) and selecting/identifying a protein that has greater activity in a) compared to b). The selected/identified protein is a conditionally active protein.SELECTED DRAWING: None |
申请公布号 |
JP2016166875(A) |
申请公布日期 |
2016.09.15 |
申请号 |
JP20160046184 |
申请日期 |
2016.03.09 |
申请人 |
HALOZYME INC |
发明人 |
LALITHA KODANDAPANI;LOUIS HOWARD BOOKBINDER;GREGORY IAN FROST;PHILIP LEE SHERIDAN;HAROLD MICHAEL SHEPARD;GE WEI;HUANG LEI |
分类号 |
G01N33/50;A61K38/00;A61K38/22;A61K38/43;A61K39/395;A61P35/00;C12Q1/02;G01N33/15;G01N33/543;G01N33/554;G01N33/566 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|